.svg){kind=small}
It is my pleasure to inform you that I have today joined Richmond Pharmacology a newly founded Phase I Unit based in London.You will be aware that Richmond Pharmacology has been set up by Dr Radivoj Arezina and Dr Ulrike Lorch in summer last year. They have since secured both substantial funding from outside investors and large premises in the well respected Atkinson Morley’s Hospital in Wimbledon. Atkinson Morley’s Hospital is a centre of clinical excellence and part of St Georges university teaching hospital and offers all the services of an acute NHS hospital in addition to the safety which can only be provided in an environment designed for the care of the most critically ill.I am now reunited with only my most excellent former colleagues from Charterhouse and we all look forward working with you again.With kind regardsDr Jorg Taubel MD AFPMManaging Director
.avif)
Latest news
Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy
September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
